ストックスクリーナーアプリを入手
1.10
0.46%
0.005
アフターアワーズ：
1.12
0.02
+1.82%
前日終値:
$1.095
開ける：
$1.1
24時間の取引高:
44,900
Relative Volume:
0.38
時価総額：
$15.16M
収益：
-
当期純損益:
$-17.93M
株価収益率:
-0.6215
EPS:
-1.77
ネットキャッシュフロー:
$-14.28M
1週間 パフォーマンス:
+12.36%
1か月 パフォーマンス:
+7.84%
6か月 パフォーマンス:
-27.15%
1年 パフォーマンス:
-51.33%
1日の値動き範囲:
$1.09
$1.12
1週間の範囲:
$0.9736
$1.12
52週間の値動き範囲:
$0.90
$2.67
Cocrystal Pharma Inc Stock (COCP) Company Profile
名前
Cocrystal Pharma Inc
セクター
電話
(786) 459-1831
住所
19805 N. CREEK PARKWAY, BOTHELL, WA
COCP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.10 | 15.09M | 0 | -17.93M | -14.28M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-07-08 | 開始されました | H.C. Wainwright | Buy |
Cocrystal Pharma Inc (COCP) 最新ニュース
Phillip Md Et Al Frost Purchases 50,000 Shares of Cocrystal Pharma (NASDAQ:COCP) Stock - Defense World
Cocrystal Pharma Inc. (COCP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Buyback Watch: How analysts rate Cocrystal Pharma Inc stock todayBull Run & Weekly Watchlist for Hot Stocks - moha.gov.vn
Financial Survey: CytomX Therapeutics (NASDAQ:CTMX) versus Cocrystal Pharma (NASDAQ:COCP) - Defense World
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k By Investing.com - Investing.com Nigeria
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k - Investing.com
Aug Decliners: Will Cocrystal Pharma Inc. stock split attract more investors - moha.gov.vn
Will Cocrystal Pharma Inc. stock benefit from upcoming earnings reportsJuly 2025 Drop Watch & Risk Controlled Swing Trade Alerts - Улправда
Why Cocrystal Pharma Inc. stock is a must watch in 2025Market Performance Summary & Safe Entry Momentum Stock Tips - Улправда
Rally Mode: Will Cocrystal Pharma Inc. stock benefit from upcoming earnings reports2025 Trade Ideas & Safe Capital Growth Stock Tips - Улправда
Why Cocrystal Pharma Inc. (8CC) stock could be top winnerJuly 2025 Sentiment & High Conviction Investment Ideas - moha.gov.vn
Is Cocrystal Pharma Inc. stock a safe haven assetJuly 2025 Price Swings & AI Powered Market Entry Strategies - DonanımHaber
Will Cocrystal Pharma Inc. stock gain from government policiesMarket Volume Summary & Long-Term Capital Growth Ideas - bolumsonucanavari.com
Will Cocrystal Pharma Inc. stock split attract more investorsEarnings Overview Summary & Weekly High Potential Alerts - DonanımHaber
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial By Investing.com - Investing.com Australia
Should I hold or sell Cocrystal Pharma Inc. stock in 2025Market Growth Report & Long-Term Safe Return Strategies - Bölüm Sonu Canavarı
Can Cocrystal Pharma Inc. stock deliver strong Q4 earnings2025 EndofYear Setup & High Conviction Buy Zone Picks - DonanımHaber
Sentiment Recap: Why Cocrystal Pharma Inc. stock is a must watch in 2025Dip Buying & Short-Term High Return Ideas - Улправда
[8-K] Cocrystal Pharma, Inc. Reports Material Event | COCP SEC FilingForm 8-K - Stock Titan
Cocrystal Pharma, Inc. Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus - marketscreener.com
Cocrystal Pharma (COCP) Set to Begin Norovirus Study with IRB Ap - GuruFocus
Cocrystal Pharma gains IRB approval for norovirus trial - TipRanks
Cocrystal Pharma Initiates Phase 1b Study for Norovirus Treatment - TradingView — Track All Markets
Cocrystal Pharma receives IRB approval from Emory University School of Medicine - marketscreener.com
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial - Investing.com
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus - GlobeNewswire
Cocrystal Pharma (NASDAQ:COCP) Shares Down 3.5% – Here’s What Happened - Defense World
Cocrystal Pharma Earnings Notes - Trefis
EPS Watch: Can Cocrystal Pharma Inc. stock deliver strong Q4 earningsQuarterly Investment Review & Reliable Intraday Trade Alerts - moha.gov.vn
Portfolio Update: Is Cocrystal Pharma Inc stock trading near support levelsWeekly Investment Report & Low Risk Investment Opportunities - moha.gov.vn
Revenue per share of Cocrystal Pharma Inc – FWB:8CC - TradingView
Why institutional investors increase stakes in Cocrystal Pharma Inc. (8CC) stockJuly 2025 Review & AI Optimized Trade Strategies - Newser
Published on: 2025-12-02 05:48:00 - Newser
How Cocrystal Pharma Inc. (8CC) stock valuation compares with sectorBond Market & Reliable Price Breakout Signals - Newser
How Cocrystal Pharma Inc. (8CC) stock behaves under inflation pressureWeekly Market Summary & Weekly High Return Opportunities - Newser
Is Cocrystal Pharma Inc. (8CC) stock among top earnings playsMarket Risk Analysis & Expert-Curated Trade Recommendations - Newser
Cocrystal Pharma to Present at Emerging Growth Conference - TipRanks
Cocrystal Pharma to Present at Noble Capital Markets Conference - TradingView
COCP Insider Trading - Quiver Quantitative
Cocrystal Pharma, Inc. to Present Clinical Progress Update at NobleCon 21 Conference - Quiver Quantitative
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference - marketscreener.com
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 By Investing.com - Investing.com South Africa
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 - Investing.com
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB By Investing.com - Investing.com South Africa
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 - Investing.com India
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 By Investing.com - Investing.com Australia
Cocrystal Pharma Inc (COCP) 財務データ
収益
当期純利益
現金流量
EPS
28.63%
大文字化:
|
ボリューム (24 時間):